AMH Equity’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59M | Buy |
+300,000
| New | +$1.59M | 2.09% | 18 |
|
|
2024
Q2 | – | Sell |
-110,000
| Closed | -$2.35M | – | 38 |
|
|
2024
Q1 | $2.35M | Buy |
+110,000
| New | +$2.35M | 2.3% | 13 |
|
|
2023
Q4 | – | Sell |
-47,285
| Closed | -$758K | – | 39 |
|
|
2023
Q3 | $758K | Sell |
47,285
-62,715
| -57% | -$1.01M | 0.83% | 22 |
|
|
2023
Q2 | $2.55M | Buy |
+110,000
| New | +$2.55M | 2.91% | 11 |
|